By Business Segment
Currently the Group has five reportable segments as follows:
Hospital and healthcare : Singapore, Malaysia, India, Greater China, Turkiye and Europe & Southeast Asia
IMU* : Education service provider in Malaysia
Labs : Diagnostic laboratory service provider in Malaysia and Singapore
PLife REIT : Real Estate Investment Trust
Others : Includes the corporate office
| Financial Year Ended 31 December | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| 3 months Actual (Unaudited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
12 months Actual (Audited) |
|
| Presented in RM mil | |||||
| Hospital and Healthcare | 5,658.7 | 19,739.6 | 16,508.5 | 16,718.4 | 12,996.1 |
| 95.02% | 94.29% | 91.77% | 97.59% | 96.95% | |
| IMU* | - | 53.9 | 260.8 | 257.6 | 248.7 |
| - | 0.26% | 1.45% | 1.50% | 1.86% | |
| Labs | 257.1 | 982.6 | 1,064.9 | - | - |
| 4.32% | 4.69% | 5.92% | - | - | |
| PLife REIT | 38.2 | 153.1 | 149.5 | 153.2 | 155.0 |
| 0.64% | 0.73% | 0.83% | 0.89% | 1.16% | |
| Others | 1.5 | 5.7 | 5.0 | 2.6 | 4.9 |
| 0.02% | 0.03% | 0.03% | 0.02% | 0.03% | |
| Total Revenue | 5,955.5 | 20,934.8 | 17,988.7 | 17,131.8 | 13,404.6 |
Note:
| * | Completed divestment of IMU on 31 March 2023 |